SPX4,256.86+49.59 1.18%
DIA336.64+2.93 0.88%
IXIC12,970.85+190.94 1.49%

BRIEF-The New England Journal Of Medicine Publishes Positive Phase 2 Data On Litifilimab In Cutaneous Lupus Erythematosus

BRIEF-The New England Journal Of Medicine Publishes Positive Phase 2 Data On Litifilimab In Cutaneous Lupus Erythematosus

Reuters · 07/28/2022 07:35
BRIEF-The New England Journal Of Medicine Publishes Positive Phase 2 Data On Litifilimab In Cutaneous Lupus Erythematosus

- Biogen Inc BIIB:

  • THE NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES POSITIVE PHASE 2 DATA ON LITIFILIMAB (BIIB059) IN CUTANEOUS LUPUS ERYTHEMATOSUS

Source text for Eikon: ID:

Further company coverage: BIIB


((Reuters.Briefs@thomsonreuters.com;))